Group One Trading
INDP icon

Group One Trading’s Indaptus Therapeutics INDP Stock Holding History

Group One Trading’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12
Closed -$4K – 7768
2020
Q4 		$4K Sell
12
-14
-54% -$6.11K ﹤0.01% 6095
2020
Q3 		$15K Buy
+26
New +$19.1K ﹤0.01% 5257
2020
Q2 		– Sell
-4
Closed -$2K – 5962
2020
Q1 		$2K Hold
4
– – ﹤0.01% 4976
2019
Q4 		$5K Sell
4
-4
-50% -$5.52K ﹤0.01% 4741
2019
Q3 		$13K Sell
8
-2
-20% -$5.95K ﹤0.01% 4512
2019
Q2 		$97K Sell
10
-3
-23% -$37.8K ﹤0.01% 3371
2019
Q1 		$221K Buy
13
+11
+550% +$193K ﹤0.01% 2616
2018
Q4 		$30K Buy
2
+1
+100% +$13.6K ﹤0.01% 3807
2018
Q3 		$11K Buy
+1
New +$9.5K ﹤0.01% 4621

Other funds holding INDP

SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's INDP Position: Q2 2025 in Review

Group One Trading held its Indaptus Therapeutics (INDP) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8254.

Group One Trading first reported a position in INDP in Q4 2018 and has held it in 8 quarters since. The position peaked at $120K in Q1 2019. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.

  • Group One Trading held 0 shares of Indaptus Therapeutics worth $0 as of Q2 2025.
  • Group One Trading left its Indaptus Therapeutics share count unchanged in Q2 2025.
  • Indaptus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2025, its #8254 holding.
  • Group One Trading first reported a position in Indaptus Therapeutics in Q4 2018 and has held it in 8 quarters since.
  • Group One Trading's Indaptus Therapeutics position peaked at $120K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.